Calidi Biotherapeutics, Inc. (CLDWW) Shareholders’ equity
Calidi Biotherapeutics, Inc. (CLDWW) shareholders’ equity at each fiscal year-end, per SEC filings.
-$50.4MFY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$50.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLDWW financial trends
CLDWW RevenueCLDWW Net incomeCLDWW Net marginCLDWW Gross profitCLDWW Gross marginCLDWW Operating incomeCLDWW Operating marginCLDWW Operating cash flowCLDWW Free cash flowCLDWW Capital expendituresCLDWW Return on equityCLDWW Stock buybacksCLDWW Dividends paidCLDWW Total assetsCLDWW Total liabilitiesCLDWW overview →